Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1071.62%
operating margin TTM
-1097.55%
revenue TTM
16.94 Million
revenue per share TTM
0.08$
valuation ratios | |
|---|---|
| pe ratio | -4.90 |
| peg ratio | 0.00 |
| price to book ratio | 6.12 |
| price to sales ratio | 43.05 |
| enterprise value multiple | -4.94 |
| price fair value | 6.12 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -1097.55% |
| pretax profit margin | -1071.62% |
| net profit margin | -1071.62% |
| return on assets | -55.68% |
| return on equity | -110.57% |
| return on capital employed | -68.18% |
liquidity ratio | |
|---|---|
| current ratio | 5.42 |
| quick ratio | 5.42 |
| cash ratio | 5.30 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.39 |
| debt equity ratio | 0.88 |
| long term debt to capitalization | 0.38 |
| total debt to capitalization | 0.47 |
| interest coverage | -896.66 |
| cash flow to debt ratio | -1.29 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.33 |
| cash per share | 0.56 |
| operating cash flow per share | -0.32 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.29 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -217.23 |
Frequently Asked Questions
When was the last time Taysha Gene Therapies, Inc. (NASDAQ:TSHA) reported earnings?
Taysha Gene Therapies, Inc. (TSHA) published its most recent earnings results on 13-11-2024.
What is Taysha Gene Therapies, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Taysha Gene Therapies, Inc. (NASDAQ:TSHA)'s trailing twelve months ROE is -110.57%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Taysha Gene Therapies, Inc. (TSHA) currently has a ROA of -55.68%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TSHA's net profit margin stand at?
TSHA reported a profit margin of -1071.62% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TSHA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.42 in the most recent quarter. The quick ratio stood at 5.42, with a Debt/Eq ratio of 0.88.